Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 425

Similar articles for PubMed (Select 2688405)

1.
2.

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.

Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW Jr, Shadur CA, et al.

Am J Kidney Dis. 1994 Nov;24(5):777-84.

PMID:
7977319
3.

Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.

Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS, et al.

Ann Intern Med. 1992 Nov 1;117(9):739-48.

PMID:
1416576
4.

Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.

Abraham PA, Opsahl JA, Rachael KM, Asinger R, Halstenson CE.

Am J Nephrol. 1990;10(2):128-36.

PMID:
2349956
7.

Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.

Watson AJ, Gimenez LF, Cotton S, Walser M, Spivak JL.

Am J Med. 1990 Oct;89(4):432-5.

PMID:
2220877
8.

Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial.

Lim VS, DeGowin RL, Zavala D, Kirchner PT, Abels R, Perry P, Fangman J.

Ann Intern Med. 1989 Jan 15;110(2):108-14.

PMID:
2909202
9.

Effect of recombinant human erythropoietin on renal function in humans.

Lim VS, Fangman J, Flanigan MJ, DeGowin RL, Abels RT.

Kidney Int. 1990 Jan;37(1):131-6.

PMID:
2299799
10.
11.

The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.

Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.

Clin Nephrol. 2001 Mar;55(3):212-9.

PMID:
11316241
12.

Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.

Stone WJ, Graber SE, Krantz SB, Dessypris EN, O'Neil VL, Olsen NJ, Pincus TP.

Am J Med Sci. 1988 Sep;296(3):171-9.

PMID:
3177433
13.

[Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].

Prata MM, de Sousa FT, Barbas JV, da Costa AM, Vinhas J, Moreira P, Abrantes C, Lopes MC.

Acta Med Port. 1990 May-Jun;3(3):149-53. Portuguese.

14.

Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction.

Muirhead N, Cattran DC, Zaltzman J, Jindal K, First MR, Boucher A, Keown PA, Munch LC, Wong C.

J Am Soc Nephrol. 1994 Nov;5(5):1216-22.

15.

Monitoring considerations in recombinant human erythropoietin therapy.

Ogden DA.

Semin Nephrol. 1989 Mar;9(1 Suppl 2):12-5. Review.

PMID:
2669080
16.

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.

Case DC Jr, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, et al.

J Natl Cancer Inst. 1993 May 19;85(10):801-6.

PMID:
8487324
17.

The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency.

Lim VS, Kirchner PT, Fangman J, Richmond J, DeGowin RL.

Am J Kidney Dis. 1989 Dec;14(6):496-506.

PMID:
2596476
19.

Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.

Mohini R.

Semin Nephrol. 1989 Mar;9(1 Suppl 1):16-21. Review.

PMID:
2648516
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk